Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Essential thrombocythemia and pregnancy

M Griesshammer1, H Heimpel, T C Pearson

  • 1Department of Hematology, University of Ulm, Germany.

Leukemia & Lymphoma
|September 1, 1996
PubMed
Summary

Essential thrombocythemia (ET) in pregnancy results in a 57% live birth rate. Aspirin (ASS) and interferon alpha (IFN) show promise, but optimal management for ET pregnancies requires further study.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Randomized phase-II trial evaluating induction therapy with idarubicin and etoposide plus sequential or concurrent azacitidine and maintenance therapy with azacitidine.

Leukemia·2019
Same author

Splanchnic vein thrombosis in myeloproliferative neoplasms: risk factors for recurrences in a cohort of 181 patients.

Blood cancer journal·2016
Same author

CD44 as a Potential Screening Marker for Preliminary Differentiation Between Congenital Dyserythropoietic Anemia Type II and Hereditary Spherocytosis.

Cytometry. Part B, Clinical cytometry·2016
Same author

Pomalidomide in myeloproliferative neoplasm-associated myelofibrosis.

Leukemia·2016
Same author

Which patients with myelofibrosis should receive ruxolitinib therapy? ELN-SIE evidence-based recommendations.

Leukemia·2016
Same author

High rate of recurrent venous thromboembolism in patients with myeloproliferative neoplasms and effect of prophylaxis with vitamin K antagonists.

Leukemia·2016

Area of Science:

  • Hematology
  • Obstetrics
  • Reproductive Medicine

Background:

  • Essential thrombocythemia (ET) is a myeloproliferative neoplasm.
  • Pregnancy in women with ET presents significant risks for both mother and fetus.

Purpose of the Study:

  • To review the outcomes of pregnancies in women with essential thrombocythemia.
  • To identify complications and evaluate potential treatment strategies.

Main Methods:

  • Literature review of 106 pregnancies in 57 women with ET.
  • Analysis of pregnancy outcomes, complications, and treatments used.

Main Results:

  • Live birth rate was 57% (60/106 pregnancies).
  • Most common complication was spontaneous abortion (36%).
  • Aspirin (ASS) and interferon alpha (IFN) showed potential benefits.

Conclusions:

  • Pregnancy in ET is associated with a high miscarriage rate.
  • ASS and IFN may improve outcomes, but further research is needed.
  • A European registry is proposed to standardize management.

Related Experiment Videos